Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of $1.01 billion. The enterprise value is $946.14 million.
| Market Cap | 1.01B |
| Enterprise Value | 946.14M |
Important Dates
The last earnings date was Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.56 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 177.56M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 35.74% |
| Float | 133.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 121.67 |
| PS Ratio | 1.18 |
| Forward PS | 1.28 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 46.92 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.68 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 129.50 |
| Debt / FCF | n/a |
| Interest Coverage | -512.12 |
Financial Efficiency
Return on equity (ROE) is -24.06% and return on invested capital (ROIC) is -12.63%.
| Return on Equity (ROE) | -24.06% |
| Return on Assets (ROA) | -3.14% |
| Return on Invested Capital (ROIC) | -12.63% |
| Return on Capital Employed (ROCE) | -7.41% |
| Weighted Average Cost of Capital (WACC) | 7.93% |
| Revenue Per Employee | $189,800 |
| Profits Per Employee | -$49,390 |
| Employee Count | 4,526 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 20.02 |
Taxes
In the past 12 months, Evotec SE has paid $17.04 million in taxes.
| Income Tax | 17.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.62% in the last 52 weeks. The beta is 1.30, so Evotec SE's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -30.62% |
| 50-Day Moving Average | 2.92 |
| 200-Day Moving Average | 3.27 |
| Relative Strength Index (RSI) | 44.05 |
| Average Volume (20 Days) | 43,803 |
Short Selling Information
The latest short interest is 66,393, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 66,393 |
| Short Previous Month | 86,146 |
| Short % of Shares Out | 0.02% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.62 |
Income Statement
In the last 12 months, Evotec SE had revenue of $859.03 million and -$223.54 million in losses. Loss per share was -$1.26.
| Revenue | 859.03M |
| Gross Profit | 91.57M |
| Operating Income | -103.92M |
| Pretax Income | -206.50M |
| Net Income | -223.54M |
| EBITDA | -19.24M |
| EBIT | -103.92M |
| Loss Per Share | -$1.26 |
Balance Sheet
The company has $512.81 million in cash and $446.75 million in debt, with a net cash position of $66.07 million or $0.37 per share.
| Cash & Cash Equivalents | 512.81M |
| Total Debt | 446.75M |
| Net Cash | 66.07M |
| Net Cash Per Share | $0.37 |
| Equity (Book Value) | 806.66M |
| Book Value Per Share | 4.54 |
| Working Capital | 331.95M |
Cash Flow
In the last 12 months, operating cash flow was $21.58 million and capital expenditures -$67.46 million, giving a free cash flow of -$45.91 million.
| Operating Cash Flow | 21.58M |
| Capital Expenditures | -67.46M |
| Depreciation & Amortization | 84.73M |
| Net Borrowing | -97.75M |
| Free Cash Flow | -45.91M |
| FCF Per Share | -$0.26 |
Margins
Gross margin is 10.66%, with operating and profit margins of -12.10% and -26.02%.
| Gross Margin | 10.66% |
| Operating Margin | -12.10% |
| Pretax Margin | -24.04% |
| Profit Margin | -26.02% |
| EBITDA Margin | -2.24% |
| EBIT Margin | -12.10% |
| FCF Margin | n/a |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.13% |
| Shareholder Yield | -0.13% |
| Earnings Yield | -22.08% |
| FCF Yield | -4.54% |
Analyst Forecast
The average price target for Evotec SE is $5.14, which is 82.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.14 |
| Price Target Difference | 82.92% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 4.38% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 20, 2021. It was a forward split with a ratio of 4:1.
| Last Split Date | Oct 20, 2021 |
| Split Type | Forward |
| Split Ratio | 4:1 |
Scores
Evotec SE has an Altman Z-Score of 0.42 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.42 |
| Piotroski F-Score | 4 |